08/09/2026
You may have recently seen the term PMOS instead of PCOS.
In May 2026, following a 14-year international consensus process, Polycystic O***y Syndrome (PCOS) was officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS).
So why the change? Because the old name didn’t accurately describe the condition.
Despite the name, ovarian “cysts” are not required for a diagnosis. In fact, many women with PCOS don’t have them at all. The term often led to confusion for both patients and healthcare professionals and placed too much emphasis on ultrasound findings.
PMOS better reflects what the condition actually is: a complex hormonal and metabolic disorder that can affect much more than the ovaries.
It can influence:
• insulin resistance
• metabolism
• menstrual cycles and ovulation
• fertility
• skin and hair
• long-term cardiometabolic health
• mental health
Importantly, the diagnostic criteria have not changed. Only the name has. The goal is to improve awareness, reduce confusion and encourage a more comprehensive approach to diagnosis and management.
As clinicians, it’s a timely reminder to look beyond the ovaries. As patients, it’s a reminder that this condition has never been “just about cysts.”
If you’ve been diagnosed with PCOS (now PMOS) and are trying to make sense of your symptoms or treatment options, an evidence-based, individualised approach can make all the difference.
Appointment link in bio.